Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • EF-TU: Travel back in time and evolve with this special protein!!!

Atherosclerosis: Combating the Killer!

World Red Cross Day 2021!!!

EF-TU: Travel back in time and evolve with this special protein!!!
  • BiotechToday
  • India

EF-TU: Travel back in time and evolve with this special protein!!!

bioxone May 7, 2021May 7, 2021

Anannya Roy, Amity University Kolkata

One of the main functions a cell performs is the synthesis of proteins. This is done with the help of a set of factors called “transcription factors”. A team of researchers from Uppasala University have succeeded in studying transcription factors that are several billion years old. The studies helped them to find out that they had much broader specificities when compared to their present-day modern counterparts. Almost all cells have an inbuilt protein synthesis factory, which consists of ribosomes and various associated translation factors which work together to ensure that any kind of protein production, be it simple or complex, runs smoothly. In today’s world, all sorts of protein-synthesizing machinery are known but the way the process evolved was still a mystery. 

The research group at Uppasala University was lead by Professor Suparna Sanyal of the Department of Cell and Molecular Biology. In a previous study, the DNA sequences of ancestors of important translation factors called elongation factor thermostable also known as EF-TU, thus moving back a billion years. These DNA sequences were used in the Uppasala research project to resurrect ancient bacterial EF-TU proteins and study the properties. Upon looking at the nodes of the evolutionary history of the protein, they were found to be 3.3 billion years old. The different environmental conditions of the earth throughout its history were found etched upon the surface of the protein. Compared to today, 3 billion years ago the temperatures were much higher so the proteins functioned optimally at 70 degree Celsius, while proteins which were 300 billion years old functioned best at 50 degree Celsius. This beautifully demonstrates how the ancestral EF-TU proteins matched geological temperatures to their corresponding periods.

These transcription/ elongation factors were found to be compatible with various types of the ribosome, hence they were called ‘Generalists’ which differs from the modern-day descendants because comparatively have much more ‘specialist’ functions. This has both pros and cons because even though they became more efficient it also means that they require specific ribosome to function. The study also sheds light on the fact that ribosomes evolved their RNA core before the other associated transcription factors.

This research provides us lots of insights into the history and evolution of this protein as well as poses possibilities of more evolutions or mutations in the future that will make them even more specialized.. The results of this research will be very helpful in pharmaceuticals research and these ancient protein variants can be used to make therapeutic proteins with little synthetic compounds. There is a large number of possibilities in this field.

Also read:Atherosclerosis: Combating the Killer!

Source: https://academic.oup.com/mbe/advancearticle/doi/10.1093/molbev/msab114/6237919

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged decades DNA EF-TU epochs Evolution genomics Molecular biology Mutation Protein proteomics ribosome RNA transcription Translation variants

One thought on “EF-TU: Travel back in time and evolve with this special protein!!!”

  1. Pingback: World Red Cross Day 2021!!! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

World Red Cross Day 2021!!!

bioxone May 8, 2021

Husna, Amity University Kolkata The purpose of living life is not just to be happy or to be successful in a particular field but, to be honourable and to be able to empathize with the people suffering around you. That happiness and pleasure which you get after helping a needy person can’t be counted on […]

World Red Cross Day

Related Post

  • BiotechToday
  • World

COVID-19: Will Social Distancing help?

bioxone October 9, 2020October 8, 2020

Sashreek Ganguly, Amity University Kolkata There is enormous evidence that inhalation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acts as a major transmission route for coronavirus disease 2019 (COVID-19). It is quintessential to discuss the various routes of viral transmission and ensure efficiency and consistency in guidelines provided to the public. To do this, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Rats have an ingroup bias similar to humans

BioTech Today July 19, 2021July 18, 2021

Parnad Basu, Amity University Kolkata Humans are social animals, and we need each other’s help here and there. At times we do tend to help, but only our friends and family. That is known as prosocial behaviour, where we do something that benefits someone else. However, we are much more reluctant when it comes to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

CRISPR/Cas9 can cure Sickle Cell Disease in Stem Cells

bioxone October 16, 2020October 15, 2020

Sashreek Ganguli, Amity University Kolkata Sickle cell disease (SCD) is a set of blood disorders inherited from parents. It is a genetic disorder caused due to A-to-T base mutation within codon 6 of the HBB/Beta-globin gene (which is a part of haemoglobin A/ HgbA) responsible for the glutamic acid to valine substitution. It affects the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy